Document is current
Any future updates will be listed below
-
Authors
Wang, Jingshu
Lai, Xiuping
Yao, Herui
Yang, Hui
Cao, Xiaolong
Wang, Xiaochen
Wang, Ying
Nian, Weiqi
Zheng, Xiaodong
Mai, Qingxiu
Liu, Anding
Lv, Xiaozhi
Bi, Xiaoying
Chen, Junyi
Wu, Junyan
Ye, Suiwen
-
Funding
Funding for this research was provided by:
Sun Yat-Sen University Clinical Research 5010 Program (2018007)
National Key Research and Development Program of China (2023YFE0204000)
GuangDong Basic and Applied Basic Research Foundation (2023A1515012412)
Science and Technology Planning Project of Guangdong Province (2023B1212060013)
National Natural Science Foundation of China (82273204)
Guangzhou Science and Technology Project (202206010078)
Sun Yat-Sen Clinical Research Cultivating Program (SYS-C-201801)
Guangzhou Science and Technology Plan Project for Joint Construction between the City and Universities (202201020278)
Guangdong Provincial Key Laboratory of Construction Foundation (2020B1212060034)
- License Information
-
More Information
Article History
Received: 15 November 2024
Accepted: 6 January 2025
First Online: 22 January 2025
Declarations
:
: All authors were investigators of this clinical study and signed a conflict of interest statement.
: The protocol of this study, any protocol amendment, the final approved informed consent form, associated supporting documents, and all types of subject recruitment documents were submitted by the investigators to ethics committees and approved by the ethics committees and regulatory authorities prior to study initiation. The ethical approval process complied with the requirements of GCP, the declaration of Helsinki and relevant laws and regulations of China. Written consent was obtained before any study specific procedures were performed. Subjects received an informed consent form from the investigator and an oral explanation of the nature, purpose, procedures, expected duration and benefits and risks of participating in the trial, expected duration and benefits and risks of participating in the trial. The subject’s informed consent form (appropriate form as approved by IEC / IRB) documented the signature and date of the subject and investigator (or authorized person).
